ArticleEuropean journal of medical research2025
Optimal number of the examined lymph nodes for different N stages in colorectal cancer.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prognostic factors of non-metastatic right colon adenocarcinoma: A multicentre retrospective analysis from the ATCCR database.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026Observational
- Oncologic standards in colon cancer resection: from margins to lymph node yield and mesentery.Frontiers in surgery · 2026Review
- More is not always better: higher lymph node yield is not associated with improved survival in stage I-III colorectal cancer.Frontiers in oncology · 2026Article
- Correlation analysis of the extent of lymph node dissection in laparoscopic radical resection of colon cancer and long-term prognosis.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The National Comprehensive Cancer Network (NCCN) recommends that at least 12 lymph nodes (LNs) should be harvested during radical surgery of colorectal cancer (CRC). This study aims to clarify the optimal number of LNs that should be examined during the radical surgery for CRC patients with each N stage. The SEER database (n = 48,331) served as the primary cohort, while the Xijing cohort (n = 4447) was used for external validation. A Cox proportional hazards regression model was employed to evaluate risk factors associated with overall survival (OS) in CRC. Moreover, the restricted cubic splines (RCS) method was used to detect inflection points within the risk function and to investigate the correlation between the number of examined lymph nodes (ELNs) and OS. Ultimately, the optimal number of ELNs for patients at different N stages was determined and verified. The analyses from both databases consistently indicated that a higher number of ELNs is an independent prognostic factor for the OS of patients with CRC. 18 and 19 are identified as the optimal numbers of ELNs for N0, N1a, and N1b, N2a stages, respectively. The Kaplan-Meier analysis revealed that there was a statistical difference in the OS between patients in the limited group and those in the adequate group among the neighboring N subgroups. For CRC patients with different N stages, the number of LNs that needs to be cleared varies. Number of ELNs exceeded 18, 18, 19 and 19 could significantly improve the prognosis of patients with N0, N1a, N1b and N2a stages, respectively.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.